ArticleMicrobial cell factories2010
Nanotechnology, bionanotechnology and microbial cell factories.
Article in Microbial cell factories, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- BeyondChemical reviews · 2025Review
- Biotechnological advances in microbial synthesis of gold nanoparticles: Optimizations and applications.3 Biotech · 2024Review
- Innovations in CAZyme gene diversity and its modification for biorefinery applications.Biotechnology reports (Amsterdam, Netherlands) · 2020Review
- Analytical study of biosynthesised silver nanoparticles against multi-drug resistant biofilm-forming pathogens.IET nanobiotechnology · 2020Article
- Exploiting Self-organization in Bioengineered Systems: A Computational Approach.Frontiers in bioengineering and biotechnology · 2017Article
- Structural and functional features of self-assembling protein nanoparticles produced in endotoxin-free Escherichia coli.Microbial cell factories · 2016Article
- Microbial glycolipoprotein-capped silver nanoparticles as emerging antibacterial agents against cholera.Microbial cell factories · 2016Article
- Non-recombinant display of the B subunit of the heat labile toxin of Escherichia coli on wild type and mutant spores of Bacillus subtilis.Microbial cell factories · 2013Article
- Systems metabolic engineering, industrial biotechnology and microbial cell factories.Microbial cell factories · 2012Article
- Adsorption of β-galactosidase of Alicyclobacillus acidocaldarius on wild type and mutants spores of Bacillus subtilis.Microbial cell factories · 2012Article
- Exploitation of marine bacteria for production of gold nanoparticles.Microbial cell factories · 2012Article
- Packaging protein drugs as bacterial inclusion bodies for therapeutic applications.Microbial cell factories · 2012Article
- Myxobacteria: natural pharmaceutical factories.Microbial cell factories · 2012Article
- Intracellular CXCR4⁺ cell targeting with T22-empowered protein-only nanoparticles.International journal of nanomedicine · 2012Article
- Biological activities of histidine-rich peptides; merging biotechnology and nanomedicine.Microbial cell factories · 2011Article
- Yeast processing bodies and stress granules: self-assembly ribonucleoprotein particles.Microbial cell factories · 2011Article
- Post-production protein stability: trouble beyond the cell factory.Microbial cell factories · 2011Article
- Engineering building blocks for self-assembling protein nanoparticles.Microbial cell factories · 2010Article
- Large-scale production of magnetosomes by chemostat culture of Magnetospirillum gryphiswaldense at high cell density.Microbial cell factories · 2010Article
- Two-stage, self-cycling process for the production of bacteriophages.Microbial cell factories · 2010Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nanotechnology is increasingly using both materials and nano-objects synthesized by living beings, most of them produced by microbial cells. Emerging technologies and highly integrative approaches (such as 'omics and systems biology), that have been largely proven successful for the production of proteins and secondary metabolites are now expected to become fully adapted for the improved biological production of nanostructured materials with tailored properties. The so far underestimated potential of microbial cell factories in nanotechnology and nanomedicine is expected to emerge, in the next years, in the context of novel needs envisaged in the nanoscience universe. This should prompt a careful revisiting of the microbial cell factories as the most versatile biological platforms to supply functional materials for nanotechnological applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.